The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change

Abstract excerpt

Abstract In pharmacogenomic studies of quantitative change, any association between genetic variants and the pretreatment (baseline) measurement can bias the estimate of effect between those variants and drug response. A putative solution is to adjust for baseline. We conducted a series of genome-wide association studies (GWASs) for low-density lipoprotein cholesterol (LDL-C) response to statin therapy in 34,874...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Associations and Epidemiology
• Share to Genomics and Rare Diseases
• Share to Lipoproteins and Cardiovascular Health